Abstract: The invention is directed to novel pyrrolopyrimidine compounds of formula (I) wherein R1, R2Y, R4, R8-R11, A and L are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are CDK4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by CDK4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer. The invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CDK4/6 activity and to the treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Abstract: A testing apparatus for testing an organic light-emitting display apparatus including: a test chamber for retaining a first substrate having a plurality of exposed cells, each cell including an organic emission unit; a stage in the test chamber, the stage configured to support the first substrate; a plurality of probe bars, each of the probe bars including a plurality of probe blocks for respectively contacting the exposed plurality of cells of the first substrate to supply an external signal to the exposed plurality of cells; a probe bar moving unit coupled to the probe bar; and a probe bar supply unit including the plurality of probe bars, wherein the probe bar moving unit is configured to move a probe bar to and from the stage and to and from the supply unit to obtain and unload a probe bar.

Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrazole compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease.

Abstract: The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, Y, Z, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.

Abstract: A method for displaying video information in a digital broadcast receiver during a change from a current channel to a new channel is disclosed. The method is suitable for displaying video information such as an advertisement, information selected by the user, or a program guide.

Abstract: An LED driver is comprising: at least two LED strings; a rectifier rectifying an alternating current (AC) voltage for supply to the LED strings; at least two balancing capacitors positioned at a current path of each LED string for carrying out a current balancing of the LED strings; at least two path control elements for controlling the current path of each LED string; and a controller controlling the path control elements.

Abstract: A method and system for improving a call drop caused by a Radio Link Failure (RLF) before handover triggering in a mobile communication system are provided. The method of improving the call drop caused by the RLF in the mobile communication system includes detecting an RLF occurring before handover triggering (RLF_before_HO), generating one of an RLF_before_HO-dependent statistics and an RLF_before_HO-dependent log file, transmitting the one of the RLF_before_HO-dependent statistics and the RLF_before_HO-dependent log file to a serving Base Station (BS), and updating a Neighbor Relation Table (NRT) and optimizing a handover parameter using the one of the RLF_before_HO-dependent statistics and the RLF_before_HO-dependent log file.

Abstract: Provided are semiconductor packages and methods of manufacturing the semiconductor package. The semiconductor packages may include a substrate including a chip pad, a redistributed line which is electrically connected to the chip pad and includes an opening. The semiconductor packages may also include an external terminal connection portion, and an external terminal connection pad which is disposed at an opening and electrically connected to the redistributed line. The present general inventive concept can solve the problem where an ingredient of gold included in a redistributed line may be prevented from being diffused into an adjacent bump pad to form a void or an undesired intermetallic compound. In a chip on chip structure, a plurality of bumps of a lower chip are connected to an upper chip to improve reliability, diversity and functionality of the chip on chip structure.

Abstract: The invention provides compounds of the formula (I): and salts, tautomers, solvates and N-oxides thereof; wherein Q is CH or N; X is N, N+—O? or CR3; Y is N, N+—O? or CR3a; R1 and R2 are independently selected from hydrogen and various substituents as defined in the claims; or R1 and R2 together with the atoms to which they are attached, link to form an optionally substituted carbocyclic or heterocyclic aromatic or non-aromatic ring of 4 to 7 members; R3 is selected from hydrogen and various substituents; and R3a is selected from hydrogen and various substituents as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds. The compounds of formula (I) have activity as inhibitors of CDK kinases and are useful in the treatment of inter alia proliferative diseases such as cancers.

Abstract: A handle for a door trim is provided, which includes a grip handle having a lower end on which a fastening portion is formed to be mounted on an armrest of the door trim and an upper end which is formed in the shape of a grip to project from the upper end. The design of the handle for the door trim is greatly changed to improve the sense of beauty, and the stiffness of the handle is increased by adding a reinforcement material to the grip handle and the door trim to heighten the durability, so that the productivity and stability of the handle can be improved.

Abstract: A mobile communication terminal, including an input unit configured to receive multimedia data corresponding to an additional service other than an established video call, a controller configured to codec-process the received multimedia data, and a transceiver configured to transmit the multimedia data during the video call.

Abstract: A handle for a door trim is provided, which includes a grip handle having a lower end on which a fastening portion is formed to be mounted on an armrest of the door trim and an upper end which is formed in the shape of a grip to project from the upper end. The design of the handle for the door trim is greatly changed to improve the sense of beauty, and the stiffness of the handle is increased by adding a reinforcement material to the grip handle and the door trim to heighten the durability, so that the productivity and stability of the handle can be improved.

Abstract: A transport apparatus including a rotary portion for providing a source of a rotary motion; a motion transfer portion for mechanically transferring a rotational force of the rotary portion; a battery pack; and a cooling portion for receiving the rotation force transferred from the motion transfer portion and cooling the battery pack by moving a fluid.

Abstract: A method and a digital broadcast receiving terminal are provided. The terminal includes a receiving unit, a decoder, a memory, and a controller. The receiving unit receives a digital multimedia broadcast transport stream and the decoder decodes data included in the transport stream. The memory stores system information obtained from a previously received transport stream. The controller provides a signal for controlling an initial broadcast receiving operation of the terminal using information stored in the memory to reduce an initial operating time required for the terminal to receive a broadcast.

Abstract: An embodiment provides an inverter transformer comprising: a first bobbin around which a first coil is wound, the first bobbin comprising a first through hole; a second bobbin around which a second coil is wound, the second bobbin comprising a second through hole; a spacer between the first and the second bobbins; and a core inserted into the first and the second through holes.

Abstract: The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, Y, Z, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.

Abstract: A semiconductor package with improved joint reliability and a method of fabricating the semiconductor package are disclosed. A conductive connector may be formed on a surface of a semiconductor wafer on which semiconductor devices may be arranged. A first insulating layer including a first opening through which a portion of the connection pad is exposed may be formed on the connection pad and the semiconductor wafer. A rewiring line electrically connected to an exposed portion of the connection pad may be formed on the first insulating layer. A second insulating layer including a second opening through which a portion of the rewiring line is exposed may be formed on the rewiring line and the first insulating layer. A connection terminal including one or more entangled wires may be formed on an exposed portion of the rewiring line so as to be electrically connected to the rewiring line.

Abstract: The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, Y, Z, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.

Abstract: The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, R4, R5, ring A, and Z are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of use compounds of Formula I in treating pathologic conditions or disorders mediated wholly or in part by deacetylases.

Abstract: The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R1, R2, R3, ring A, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.